Use Open Families to Combat Design-Arounds
A perennial challenge in patenting is to both cover your product and block design-arounds. It is understandably frustrating to incur the expense and disclosure requirements of the patent process only…
A young businessman or scientist with robotic hand and safety glasses standing in office, working.
Your Employee Handbook May be Deficient for Capturing Patent Rights
By Dominic Frisina Is your employee handbook sufficient to capture patent rights in your employee’s inventions? The Federal Circuit case of Omni Medsci v. Apple illustrates one reason why it…
Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology on laboratory background.
Amgen is Not the End of Chemical Innovation
By Dominic A. Frisina Some chemical innovators have found the recent Supreme Court decision in Amgen v. Sanofi to suggest that chemical inventions will be subject to new and draconian disclosure…
Close up of human hands. Man holding the medicine bottle in one hand and pill in other
Amgen Ratifies CAFC’s Requirement to Enable a Claim’s Full Scope
By Dominic A. Frisina, and Hannah P. Mink The Court’s reasoning in Amgen v. Sanofi upholds the Federal Circuit’s long-standing requirement to enable the full scope of a claimed invention.…
Guardian of Law seated marble figure outside the Supreme Court of the United States
SCOTUS to Rule on Abitron’s Foreign Application of the Lanham Act
By Dominic A. Frisina Can the Lanham Act apply to the conduct of foreign entities occurring entirely outside the United States and, if so, what is the test? The…
Assignor Estoppel is Alive and Well after Minerva v. Hologic
The Supreme Court clarified the doctrine of assignor estoppel in its June 29th Minerva v. Hologic opinion.[1] In doing so, the Court vacated the Federal Circuit’s opinion estopping Minerva from…